Suspension of trading
Centessa Pharmaceuticals plc Share Price
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 24/06/2026 am IST
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 24/06 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 24/06 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 626.66Cr 539.93Cr 511.24Cr 463.39Cr 869.35Cr 60TCr 873.75Cr 6.07TCr 2.33TCr 30TCr 2.35TCr 2.3TCr 96TCr | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 609.04Cr 524.75Cr 496.87Cr 450.36Cr 844.91Cr 58TCr 849.19Cr 5.9TCr 2.27TCr 30TCr 2.29TCr 2.24TCr 94TCr | EV / Sales 2024 |
-
| EV / Sales 2025 | 23,18,10,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 3 months | +1.84% | ||
| 6 months | +43.52% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 17.05 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/06/26 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -1,99,63,157 | 12.9020% | |
| 01/05/26 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 26/03/26 | Exercice | Executive/Senior Manager | 71,994 | 0.0539% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +78.65% | +517.38% | 626.65Cr | |
| -0.71% | -6.35% | -4.87% | +9.03% | 4.55TCr | |
| +0.21% | -2.98% | +340.68% | +519.93% | 4.37TCr | |
| +1.74% | -2.24% | +37.28% | +21.57% | 4.31TCr | |
| +1.38% | -3.28% | +3.23% | +65.60% | 3.94TCr | |
| -1.44% | -5.26% | +8.78% | +36.85% | 3.19TCr | |
| +0.87% | -2.60% | - | - | 1.73TCr | |
| +0.75% | -0.64% | +18.07% | +110.32% | 1.64TCr | |
| -0.31% | -2.78% | +10.47% | +30.49% | 1.42TCr | |
| +1.93% | -3.55% | +74.20% | +39.37% | 1.33TCr | |
| Average | +0.52% | -3.03% | +62.94% | +150.06% | 2.71TCr | |
| Weighted average by Cap. | +0.42% | -3.54% | +73.30% | +133.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 12.92 12.24 11.09 20.81 1.43T 20.91 145.34 55.89 729.06 56.33 55.1 2.3T |
| Net income | -24Cr -20Cr -19Cr -17Cr -33Cr -2.25TCr -33Cr -228.43Cr -88Cr -1.15TCr -89Cr -87Cr -3.62TCr | -20Cr -17Cr -16Cr -15Cr -27Cr -1.89TCr -28Cr -191.4Cr -74Cr -960.09Cr -74Cr -73Cr -3.03TCr |
| Net Debt | -36Cr -31Cr -30Cr -27Cr -51Cr -3.48TCr -51Cr -353.03Cr -135.76Cr -1.77TCr -136.83Cr -133.83Cr -5.6TCr | -18Cr -15Cr -14Cr -13Cr -24Cr -1.68TCr -25Cr -170.73Cr -66Cr -856.4Cr -66Cr -65Cr -2.71TCr |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
